Furthermore, several lines of evidence, including aberrant expression of OTUD7B, and its tight correlation with high tumor grades and shorter metastasis free survival, indicate OTUD7B as a potential marker for predicting adverse prognosis in breast cancer patients. Here, OTUD7B is linked to neoplasm.